Organizational Engagement With Poverty: A Review and Reorientation

Recognizing the potential contributions businesses can make to address the grand challenge of global poverty, management scholars have increasingly turned research attention to poverty. We conducted an integrative review of poverty studies in the organizational literature spanning from 1985 to 2022. Based on the review, we clarify poverty as a significant lack of market-oriented resources, opportunities, and capabilities. Further, we develop a framework that captures the ways in which organizational practices offer the poor, or deprive them of, resources, opportunities, and capabilities, and thereby contribute to poverty alleviation or aggravation respectively. Moreover, our framework identifies the necessary support conditions for an organization to effectively combat poverty. We conclude by proposing a research agenda aimed at advancing management scholarship on poverty

Phases of quartic scalar theories and PT symmetry

For quantum mechanical anharmonic oscillator-type Hamiltonians, it is shown that there is a relation between the energy eigenvalues of parity symmetric and PT-symmetric phases for weak coupling. The possibility of such a relation was conjectured by Ai, Bender, and Sarkar on examining the imaginary part of the ground state energy using path integrals. In the weak coupling limit, we show that the conjecture is true also for the real part of the ground state energy and of the excited state energies. However, the conjecture is false for strong coupling. The analogous relation for partition functions in zero spacetime dimensions is valid for many cases. However O(N) symmetric multicomponent scalar fields, with N&gt;1 and a quartic interaction, do not satisfy the conjecture for zero and one dimensional spacetime. The possibility that the conjecture is valid, for a single component field theory in higher dimensional spacetimes, is discussed in a simplified model.</p

“Bigger lows, but higher highs”: A qualitative exploration of the similarities and differences in quality of life of middle-aged and older autistic and non-autistic adults.

*Francis and Hershman as joint-first authorsABSTRACTBackground: Autistic adults often report lower subjective quality of life (QoL) than non-autistic adults. Despite older age also often being associated with lower QoL, little is known about the first-hand experiences of, and influences on, QoL for middle-aged and older autistic adults compared with their non-autistic peers.Method: Thirty-three participants (autistic n=15, non-autistic n=18) aged 50-89 years completed semi-structured interviewed that explored their QoL. Responses were thematically analysed, and themes were compared to identify similarities and differences between groups.Results: Both autistic and non-autistic groups reported similar QoL experiences, but with subtle differences. Social support from family and friends was important for both groups. Both noted shrinking social networks with age, but the non-autistic group was often less satisfied with their social lives. Concerns about health and sleep changes were common, but autistic participants often mentioned persistent mental health issues affecting their wellbeing. Autistic individuals also highlighted sensorysensitivities and difficulties with change. Receiving their autism diagnosis was significant for autistic participants, aiding self-acceptance. Acceptance of age-related changes was common in both groups, but the autistic group was more willing to seek support, while the non-autistic group often saw asking for help as losing their independence.Conclusions: These findings highlight similarities and differences in aspects relevant to QoL for middle-aged and older autistic and non-autistic adults. While many similarities were found, the autistic group reported subtle differences in their experiences. Experiences such as social connectedness and coping with change could be targeted to improve the QoL of ageing autistic adults

Who Is Competing at the Elite Level? Exploring Impairment, Gender, and Nationality of International Blind and Partially Sighted Footballers

Classification in para sports aims to create equitable competition. Footballers with vision impairments are allocated to one of three classes (B1, B2, or B3). This work aimed to understand the effectiveness and inclusivity of the current classification system. Visual acuity (VA) and/or visual field of male and female international footballers was extracted anonymously via the International Blind Sports Federation classification database. The analysis included 562 individuals. Footballers were predominantly male (88.26%); 11.74% were female. Only VA was used to classify 99.11% of footballers, and only 4.50% had visual field included in their classification. VA was nonnormally distributed for all three classes. Only 2.84% of footballers had a VA between 2.10 and 2.60 logMAR, suggesting that VAs in this range and/or visual-field impairment may disproportionately impact performance compared with other footballers within their classes. The current classification system does not appear to be inclusive or create equitable competition

Fragmented Frontiers: Three Approaches to Understanding Irregular Warfare

This article surveys current thinking, both academic and doctrinal, on the subject of irregular warfare. It argues that from a western perspective the debate has essentially resulted in three competing forms of understanding, what this paper terms the maximal, traditional, and competition-disruption models. Conceptually, all have certain strengths but also a number of highly significant weaknesses. It nevertheless proposes that the last of these, particularly when articulated as a form of ‘strategic disruption’, offers the most coherent vision of irregular warfare. Even then, significant gaps in reasoning still exist. Ultimately, the ability of western thinkers and doctrine writers to agree a common understanding of irregular warfare remains an inherently fragile endeavor

Psychedelic-assisted treatment for substance use disorder:A narrative systematic review

Background and aimsThis is the first systematic review of the extant literature on all major psychedelic-assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic-assisted treatment for AUD, TUD, and SUD; to evaluate its quality; and to offer recommendations for research.MethodsThis was a prospectively registered narrative systematic review of open-label, randomised controlled trials (RCT), and observational studies of d-lysergic acid diethylamide (LSD), mescaline, psilocybin, ayahuasca, ketamine, ibogaine and 3,4-methylenedioxymethamphetamine (MDMA). Eligible studies had SUD outcome measures including craving, substance use, relapse, and remission. Study quality was evaluated using the Cochrane Collaboration Risk of Bias (RoB), and Cochrane Collaboration RoB in Non-randomised Studies of Interventions tool. Certainty of evidence for RCTs was judged using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) tool.Findings37 studies (2035 participants) were reviewed: LSD (14; n = 1047); mescaline (1; n = 7); psilocybin (4; n = 135); ayahuasca (3; n = 101); ketamine (10; n = 579); ibogaine (5; n = 166); and MDMA (1; n = 14). There were no serious adverse events reported in any study. A two-centre, placebo-controlled, phase 2 superiority RCT of psilocybin for AUD, and a two-centre, double-blind, four-arm, placebo-controlled phase 2 RCT of ketamine for AUD yielded the best evidence of efficacy. Progression support to a phase 3 trials was secured from an open-label phase 2 study of psilocybin for TUD and nine phase 2 RCTs of ketamine for AUD, cannabis use disorder, cocaine use disorder, and opioid use disorder (all nine with high-RoB and low-GRADE evidence certainty).ConclusionsPsilocybin-assisted treatment for alcohol use disorder appears to have the best evidence of efficacy among all major psychedelic-assisted treatments for alcohol, tobacco, and other substance use disorders. Future research of psychedelic-assisted treatment should report all safety events; screen for person-level characteristics indicating that psychedelic-assisted substance use disorders treatment is contraindicated; strive to mitigate blinding of participants to interventions; use factorial designs for drug and psychotherapy randomised controlled trials; and build consensus for a field-specific Core Outcome Set.<p/